We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Expert Opinion / Cases · May 07, 2018

Management of Axilla in Clinically Stage I Breast Cancer With Node Positive Disease on SLN Biopsy

Written by
Sameer Nasir MD

 

Discuss This item Follow

No comments yet, be the first to start the discussion!

  • KANNAN VENKATESAN

    Ca. left Breast, pT1b N1a The treatment Plan for such a patient in our department: Breast +Axillary RT., with or without SCF RT as given below Her age is >50, T1lesion, ER positive, G-1tumour. If there is no LVI, RT plan will be Whole breast Rt including level I & II axilla. Contour will be done for Level I & II axilla which will be included in the Breast field as modified tangents. Dose will be 42.7Gy/16Fr followed by supplement RT to breast tumour bed-10Gy/5Fr. RT will be delivered by deep inspiratory breath hold method, 4D-RT, to reduce the cardiac dose If LVI is present, then add additional field to cover axilla level-III with SCF to a dose 45Gy/20Fr Even if Oncotype DX score is low, the plan will be the same because of N1a status


  • Luca Licata

    Considering the low tumor burden (T1b and only one positive lymph node) and its biologic characteristics (G1, ER/PR +), I probably would not propose the use of post-mastectomy RT. I would prescribe only adjuvant endocrine therapy


  • Sep 30, 2020

    Pending Moderator approval.
    Delete

Further Reading